C83.70 Burkitt lymphoma, unspecified site

Name of the Condition

• Burkitt lymphoma, unspecified site
• Medical term: Burkitt's lymphoma

Summary

Burkitt lymphoma is a highly aggressive form of non-Hodgkin lymphoma that primarily affects B-cells in the lymphatic system. It is characterized by rapid tumor growth and is often associated with specific genetic and viral factors. Early diagnosis and treatment are critical due to its fast progression.

Causes

The exact causes of Burkitt lymphoma are not fully understood, but it is strongly linked to infection with the Epstein-Barr virus (EBV). Genetic mutations, particularly chromosomal translocations involving the MYC gene, are also key contributors to its development.

Risk Factors

• Epstein-Barr virus (EBV) infection
• Human immunodeficiency virus (HIV) infection
• Weakened immune system from other conditions or treatments
• Young age, especially in children and young adults
• Geographic regions with high EBV prevalence, such as equatorial Africa

Symptoms

• Rapidly growing, painless lymph node swelling
• Abdominal pain or swelling (if lymphoma affects the abdomen)
• Fever
• Night sweats
• Unexplained weight loss
• Fatigue

Diagnosis

Diagnosis involves a physical examination to assess lymph node or organ swelling, followed by imaging tests (e.g., CT or MRI) to identify tumor locations. A biopsy of affected tissue is performed to confirm the presence of cancerous cells and determine the specific type of lymphoma. Blood tests may also be used to evaluate overall health and detect markers associated with the disease.

Treatment Options

• Chemotherapy: Intensive systemic therapy is the primary treatment, often using combination regimens to target rapidly dividing cancer cells.
• Immunotherapy: May be used to enhance the body's immune response against cancer cells.
• Stem Cell Transplant: Considered in certain cases, particularly for relapsed or high-risk disease.
• Supportive Care: Includes managing symptoms and side effects to improve quality of life during treatment.

Prognosis and Follow-Up

Prognosis depends on factors such as the stage of the disease, patient age, and response to treatment. Early-stage disease often has a better outcome with aggressive therapy. Regular follow-up appointments, including imaging and blood tests, are essential to monitor for recurrence or complications.

Complications

• Tumor lysis syndrome (due to rapid cell breakdown during treatment)
• Infections from a weakened immune system
• Organ dysfunction if the lymphoma spreads to vital organs
• Long-term effects from chemotherapy or radiation therapy

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular medical care.
• Avoid known risk factors, such as minimizing exposure to viruses like EBV where possible.
• Follow recommended screening guidelines if at increased risk (e.g., due to HIV or family history).

When to Seek Professional Help

Seek immediate medical attention if you experience unexplained, rapidly growing lymph node swelling, persistent fever, night sweats, or unexplained weight loss. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use code C83.70 for Burkitt lymphoma when the site is not specified. Ensure documentation supports the absence of a more specific site (e.g., axilla, abdomen) to justify the unspecified designation. Verify that the diagnosis aligns with clinical findings and that no additional codes are needed for site-specific involvement.